Leo Kim

Leo Kim is a seasoned biotech professional with a diverse background spanning business operations, strategy, R&D, market access, and public policy.

He excels in leadership, new business formation, and organizational management, bringing to the table an entrepreneurial spirit and a proactive 'go-getter' attitude tailored for executive roles and high-growth teams.

Leo holds a Doctor of Philosophy (PhD) in Neuroscience from the University of Pennsylvania School of Medicine and a Bachelor of Science (BS) in Chemistry and Biological Sciences from the Korea Advanced Institute of Science and Technology.

His career journey includes notable positions such as Vice President of Business Operations at CG Pharmaceuticals, Inc., Vice President of Business Operations at Deliberate AI, and Head of Business Planning and Operations, Haematology R&D at AstraZeneca.

He has also served as Director, U.S. Value Strategy & Evidence at AstraZeneca, Board Member at the Virginia Department for the Blind and Vision Impaired, Director of Corporate Operations at Incyte, and Board Director at The Night Ministry.

Leo Kim has brought his expertise to roles like Chief of Staff (Baxter / Baxalta) at Baxter International Inc., Associate at McKinsey & Company, and Research Manager at Rexahn Pharmaceuticals.

His specialties lie in Pharmaceuticals, biotechnology, market access, healthcare policy, business operations, management consulting, business strategies and development, operational excellence, R&D, market research, patient advocacy, entrepreneurship, and government leadership.